205 related articles for article (PubMed ID: 7710941)
1. c-erbB-3 protein expression in ovarian tumours.
Simpson BJ; Weatherill J; Miller EP; Lessells AM; Langdon SP; Miller WR
Br J Cancer; 1995 Apr; 71(4):758-62. PubMed ID: 7710941
[TBL] [Abstract][Full Text] [Related]
2. c-erbB growth-factor-receptor proteins in ovarian tumours.
Simpson BJ; Phillips HA; Lessells AM; Langdon SP; Miller WR
Int J Cancer; 1995 Jun; 64(3):202-6. PubMed ID: 7622309
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical localization of c-erbB-2 protein and epidermal growth factor receptor in normal surface epithelium, surface inclusion cysts, and common epithelial tumours of the ovary.
Wang DP; Konishi I; Koshiyama M; Nanbu Y; Iwai T; Nonogaki H; Mori T; Fujii S
Virchows Arch A Pathol Anat Histopathol; 1992; 421(5):393-400. PubMed ID: 1360720
[TBL] [Abstract][Full Text] [Related]
4. C-erbB-3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicators.
Travis A; Pinder SE; Robertson JF; Bell JA; Wencyk P; Gullick WJ; Nicholson RI; Poller DN; Blamey RW; Elston CW; Ellis IO
Br J Cancer; 1996 Jul; 74(2):229-33. PubMed ID: 8688326
[TBL] [Abstract][Full Text] [Related]
5. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
[TBL] [Abstract][Full Text] [Related]
6. Type 1 protein tyrosine kinases in benign and malignant breast lesions.
Suo Z; Emilsen E; Tveit KM; Nesland JM
Histopathology; 1998 Dec; 33(6):514-21. PubMed ID: 9870145
[TBL] [Abstract][Full Text] [Related]
7. Dual colour flow cytometry of p53 and c-erbB-2 expression related to DNA aneuploidy in primary and metastatic breast cancer.
Clark JS; George WD; Campbell AM
Cancer Lett; 1992 Oct; 66(3):193-200. PubMed ID: 1360329
[TBL] [Abstract][Full Text] [Related]
8. c-erbB-2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer.
Lipponen HJ; Aaltomaa S; Syrjänen S; Syrjänen K
Anticancer Res; 1993; 13(4):1147-52. PubMed ID: 8102517
[TBL] [Abstract][Full Text] [Related]
9. Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis.
Lipponen P; Eskelinen M
Br J Cancer; 1994 Jun; 69(6):1120-5. PubMed ID: 7911031
[TBL] [Abstract][Full Text] [Related]
10. c-erbB-3 protein expression in human breast cancer: comparison with other tumour variables and survival.
Quinn CM; Ostrowski JL; Lane SA; Loney DP; Teasdale J; Benson FA
Histopathology; 1994 Sep; 25(3):247-52. PubMed ID: 7821892
[TBL] [Abstract][Full Text] [Related]
11. Expression of C-erb B2 in tumours and tumour-like lesions of the thyroid.
Soares P; Sambade C; Sobrinho-Simões M
Int J Cancer; 1994 Feb; 56(3):459-61. PubMed ID: 7906256
[No Abstract] [Full Text] [Related]
12. Expression of the c-erbB-2 (HER-2/neu) oncoprotein in human prostatic carcinoma.
Kuhn EJ; Kurnot RA; Sesterhenn IA; Chang EH; Moul JW
J Urol; 1993 Nov; 150(5 Pt 1):1427-33. PubMed ID: 8105108
[TBL] [Abstract][Full Text] [Related]
13. Expression of pro-apoptotic (p53, p21, bax, bak and fas) and anti-apoptotic (bcl-2 and bcl-x) proteins in serous versus mucinous borderline ovarian tumours.
Fauvet R; Dufournet C; Poncelet C; Uzan C; Hugol D; Daraï E
J Surg Oncol; 2005 Dec; 92(4):337-43. PubMed ID: 16299808
[TBL] [Abstract][Full Text] [Related]
14. c-erbB-3 and c-erbB-2 protein expression in node-negative breast carcinoma--an immunocytochemical study.
Gasparini G; Gullick WJ; Maluta S; Dalla Palma P; Caffo O; Leonardi E; Boracchi P; Pozza F; Lemoine NR; Bevilacqua P
Eur J Cancer; 1994; 30A(1):16-22. PubMed ID: 7908213
[TBL] [Abstract][Full Text] [Related]
15. Brenner tumours of the ovary: a study of the histology, immunohistochemistry and cellular DNA content in benign, borderline and malignant ovarian tumours.
Trebeck CE; Friedlander ML; Russell P; Baird PJ
Pathology; 1987 Jul; 19(3):241-6. PubMed ID: 3324024
[TBL] [Abstract][Full Text] [Related]
16. Expression of the c-erbB-3 protein in gastrointestinal tract tumours determined by monoclonal antibody RTJ1.
Rajkumar T; Gooden CS; Lemoine NR; Gullick WJ; Goden CS
J Pathol; 1993 Jul; 170(3):271-8. PubMed ID: 8133400
[TBL] [Abstract][Full Text] [Related]
17. Expression and prognostic significance of Bcl-2 in ovarian tumours.
Henriksen R; Wilander E; Oberg K
Br J Cancer; 1995 Nov; 72(5):1324-9. PubMed ID: 7577491
[TBL] [Abstract][Full Text] [Related]
18. Expression of c-erbB proto-oncogene family members in squamous cell carcinoma of the head and neck.
Ibrahim SO; Vasstrand EN; Liavaag PG; Johannessen AC; Lillehaug JR
Anticancer Res; 1997; 17(6D):4539-46. PubMed ID: 9494565
[TBL] [Abstract][Full Text] [Related]
19. MDM2 Expression in Serous and Mucinous Epithelial Tumours of the Ovary.
Abdelaal SE; Habib FM; El Din AA; Gabal SM; Hassan NS; Ibrahim NA
Asian Pac J Cancer Prev; 2016; 17(7):3295-300. PubMed ID: 27509966
[TBL] [Abstract][Full Text] [Related]
20. Receptors for hormones and growth factors and (onco)-gene amplification in human ovarian cancer.
Berns EM; Klijn JG; Henzen-Logmans SC; Rodenburg CJ; van der Burg ME; Foekens JA
Int J Cancer; 1992 Sep; 52(2):218-24. PubMed ID: 1325950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
